Inventor
BROWN BRIAN S
US21 patents
⚠️ This page may combine multiple inventors who share the name “BROWN BRIAN S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBOTT LAB
9 patentsUS7129235B2Oct 31, 2006
Amides useful for treating pain
ABBOTT LAB32 citations92
US7622493B2Nov 24, 2009
Antagonists of the vanilloid receptor subtype 1 (VR1) and uses thereof
ABBOTT LAB6 citations73
US7348343B2Mar 25, 2008
Amides useful for treating pain
ABBOTT LAB8 citations73
US7998982B2Aug 16, 2011
Amide derivatives as TRPV1 antagonists
ABBOTT LAB4 citations62
US7767705B2Aug 3, 2010
Compounds that inhibit TRPV1 and uses thereof
ABBOTT LAB3 citations62
US7615570B2Nov 10, 2009
Antagonists to the vanilloid receptor subtype 1 (VR1) and uses thereof
ABBOTT LAB5 citations62
US7037927B2May 2, 2006
Amides that inhibit vanilloid receptor subtype 1 (VR1) receptor
ABBOTT LAB3 citations62
US7595332B2Sep 29, 2009
Amides that inhibit vanilloid receptor subtype 1 (VR1)
ABBOTT LAB1 citations52
US7812019B2Oct 12, 2010
Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof
ABBOTT LAB0 citations51
ABBVIE SARL
4 patentsUS10259810B2Apr 16, 2019
N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
ABBVIE SARL5 citations82
US9890158B2Feb 13, 2018
N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
ABBVIE SARL5 citations81
US10647717B2May 12, 2020
N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
ABBVIE SARL1 citations71
US10130622B2Nov 20, 2018
Compounds for treatment of cystic fibrosis
ABBVIE SARL0 citations37